Monoclonal Antibody

Trastuzumab

Trastuzumab is a monoclonal antibody that targets the HER2 protein.

Research Overview

HER2 is a protein studied in oncology and targeted therapy. Trastuzumab is part of CHENGENE's monoclonal antibody research portfolio.

Research Enquiry ↗

CHENGENE PRIVATE LIMITED

Advancing biotechnology through research.

Contact our team for further information about CHENGENE's research and development portfolio. Product availability, development status and regulatory details should be confirmed directly with the company.